Log In
BCIQ
Print this Print this
 

NL004

  Manage Alerts
Collapse Summary General Information
Company Beijing Northland Biotech Co. Ltd.
DescriptionRecombinant human thymosin alpha 1
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationThrombocytopenia
Indication DetailsTreat chemotherpay induced thrombocytopenia
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today